StartupsFinSMEsabout 2 hours ago
Cyllene Therapeutics Raises €33M in Series C Funding
1 min read
Cyllene Therapeutics secured €33 million in Series C funding. The financing round supports the company's development of RNA-based therapies for cancer and other diseases. The funding will advance clinical programs and expand research capabilities.
Level
Hype check
Tap to vote and see what everyone thinks.
